Molecular characterization of multidrug- and extensively drug-resistant mycobacterium tuberculosis strains in Jiangxi, China

Journal of Clinical Microbiology

Volumn 50, Issue 7, 2012, Pages 2404-2413

  Yuan, Xiaoliang ^a   Zhang, Tiantuo ^a   Kawakami, Kazuyoshi ^b   Zhu, Jiaxin ^a   Li, Hongtao ^a   Lei, Jianping ^c   Tu, Shaohua ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Jiang Xi Chest Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ARGININE; ASPARAGINE; CAPREOMYCIN; ISOLEUCINE; ISONIAZID; KANAMYCIN; LYSINE; OFLOXACIN; RIFAMPICIN; SERINE; VALINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DNA SEQUENCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GYRA GENE; GYRB GENE; HUMAN; KATG GENE; MABA INHA GENE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RPOB GENE; RRS GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENETIC VARIATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84862729699     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06860-11     Document Type: Article

References (55)

1. Afanas'ev MV, et al. 2007. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J. Antimicrob. Chemother. 59:1057-1064.
2. Ajbani K, Rodrigues C, Shenai S, Mehta A. 2011. Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India. J. Clin. Microbiol. 49:1588-1590.
3. Allix-Beguec C, Harmsen D, Weniger T, Supply P, Niemann S. 2008. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 46:2692-2699.
4. Almeida DSPE, Palomino JC. 2011. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J. Antimicrob. Chemother. 66:1417-1430.
5. Ando H, et al. 2010. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 54:1793-1799.
6. Borrell S, Gagneux S. 2009. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13:1456-1466.
7. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. 2010. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48:1683-1689.
8. Caminero JA, Sotgiu G, Zumla A, Migliori GB. 2010. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect. Dis. 10:621-629.
9. Campbell PJ, et al. 2011. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041.
10. Caws M, et al. 2006. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol. 44:2333-2337.
11. Chan ED, et al. 2004. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 169:1103-1109.
12. Chang KC, Yew WW, Chan RC. 2010. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 65:1551-1561.
13. Chen J, et al. 2007. Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 87:446-449.
14. Chen L, et al. 2010. rpoB gene mutation profile in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Guizhou, one of the highest incidence rate regions in China. J. Antimicrob. Chemother. 65:1299-1301.
15. Cheng AF, et al. 2004. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob. Agents Chemother. 48:596-601.
16. Devaux I, Kremer K, Heersma H, Van Soolingen D. 2009. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg. Infect. Dis. 15:1052-1060.
17. Duanmu H. 2002. Report on fourth national epidemiological sampling survey of tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 25:3-7. (In Chinese.)
18. Duong DA, et al. 2009. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob. Agents Chemother. 53:4835-4839.
19. Engstrom A, Perskvist N, Werngren J, Hoffner SE, Jureen P. 2011. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 66:1247-1254.
20. Evans J, Segal H. 2010. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 65:897-900.
21. Feuerriegel S, et al. 2009. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob. Agents Chemother. 53:3353-3356.
22. Gagneux S, et al. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946.
23. Gandhi NR, et al. 2010. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830-1843.
24. Gandhi NR, et al. 2010. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am. J. Respir. Crit. Care Med. 181:80-86.
25. Ginsburg AS, Grosset JH, Bishai WR. 2003. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect. Dis. 3:432-442.
26. Hoek KG, et al. 2008. Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 46:1369-1373.
27. Jugheli L, et al. 2009. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob. Agents Chemother. 53:5064-5068.
28. Lau RW, et al. 2011. Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74. Antimicrob. Agents Chemother. 55:608-614.
29. Lee AS, Lim IH, Tang LL, Telenti A, Wong SY. 1999. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43:2087-2089.
30. Lee AS, Lim IH, Tang LL, Wong SY. 2005. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J. Clin. Microbiol. 43:2026-2027.
31. Maus CE, Plikaytis BB, Shinnick TM. 2005. Molecular analysis of crossresistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:3192-3197.
32. Maus CE, Plikaytis BB, Shinnick TM. 2005. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:571-577.
33. Miotto P, Piana F, Cirillo DM, Migliori GB. 2008. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 46:393-394.
34. Nusrath UA, Selvakumar N, Narayanan S, Narayanan PR. 2008. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Int. J. Antimicrob. Agents 31:71-75.
35. Pantel A, et al. 2011. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:4524-4529.
36. Parsons LM, et al. 2011. Laboratory diagnosis of tuberculosis in resourcepoor countries: challenges and opportunities. Clin. Microbiol. Rev. 24:314-350.
37. Prammananan T, et al. 2008. Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDR TB) strains from Thailand and development of a rapid method for mutation detection. Clin. Microbiol. Infect. 14:446-453.
38. Ramasubban G, et al. 2011. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His, and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches. Int. J. Antimicrob. Agents 37:368-372.
39. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79:3-29.
40. Ramaswamy SV, et al. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250.
41. Sandgren A, et al. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6:e2. doi:10.1371/journal.pmed.1000002.
42. Sekiguchi J, et al. 2007. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:179-192.
43. Sheng J, et al. 2008. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J. Appl. Microbiol. 105:904-911.
44. Somerville W, Thibert L, Schwartzman K, Behr MA. 2005. Extraction of Mycobacterium tuberculosis DNA: a question of containment. J. Clin. Microbiol. 43:2996-2997.
45. Supply P, et al. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510.
46. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony. Methods Mol. Biol. Evol. 28:2731-2739.
47. WHO. 2011. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015: WHO progress report 2011. WHO/HTM/TB/2011.3. World Health Organization, Geneva, Switzerland.
48. WHO.2009. Guidelines for surveillance of drug resistance in tuberculosis, 4th ed. WHO/HTM/TB/2009.422. World Health Organization, Geneva, Switzerland.
49. WHO. 2010. Global tuberculosis control: WHO report 2010. WHO/HTM/TB/2010.7. World Health Organization, Geneva, Switzerland.
50. Xu P, et al. 2009. Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China. Antimicrob. Agents Chemother. 53:3170-3172.
51. Yin X, Yu Z. 2010. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J. Infect. 61:150-154.
52. Zakerbostanabad S, Titov LP, Bahrmand AR. 2008. Frequency and molecular characterization of isoniazid resistance in katG region of MDR isolates from tuberculosis patients in southern endemic border of Iran. Infect. Genet. Evol. 8:15-19.
53. Zaunbrecher MA, Sikes RD, Jr, Metchock B, Shinnick TM, Posey JE. 2009. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 106:20004-20009.
54. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13:1320-1330.
55. Zhao M, et al. 2009. Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 4:e4370. doi:10.1371/journal.pone.0004370.